Last reviewed · How we verify

Ropivacaine instillation

San Gerardo Hospital · Phase 3 active Small molecule

Ropivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.

Ropivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials. Used for Postoperative pain management via surgical site instillation, Intraoperative local anesthesia during surgical procedures.

At a glance

Generic nameRopivacaine instillation
Also known asRopivacaine, Instillation
SponsorSan Gerardo Hospital
Drug classLocal anesthetic (amide)
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia / Pain Management
PhasePhase 3

Mechanism of action

Ropivacaine is an amide-type local anesthetic that reversibly inhibits sodium influx into nerve fibers, thereby preventing depolarization and nerve impulse transmission. When instilled into surgical or procedural sites, it provides localized anesthesia and analgesia by blocking sensory and motor nerve conduction in the area of administration. This mechanism allows for pain control during and after surgical procedures without systemic anesthesia.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: